Business Description
Cell Impact
ISIN : SE0025940513
Share Class Description:
FRA:ICL: Class BTotal Employee Number:
29Compare
Compare
Traded in other countries / regions
CI.SwedenICL.Germany IPO Date
2013-03-15Description
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.29 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -7.77 | |||||
Beneish M-Score | -0.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -73.8 | |||||
3-Year EBITDA Growth Rate | 46.3 | |||||
3-Year EPS without NRI Growth Rate | 32.4 | |||||
3-Year FCF Growth Rate | 59.5 | |||||
3-Year Book Growth Rate | -62.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.01 | |||||
9-Day RSI | 45.81 | |||||
14-Day RSI | 46.58 | |||||
3-1 Month Momentum % | 15 | |||||
6-1 Month Momentum % | -14.8 | |||||
12-1 Month Momentum % | 880.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.06 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 1931.84 | |||||
Days Sales Outstanding | 108.04 | |||||
Days Payable | 154.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -92.3 | |||||
Shareholder Yield % | 5.73 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -42.73 | |||||
Operating Margin % | -2129.79 | |||||
Net Margin % | -2219.87 | |||||
EBITDA Margin % | -876.65 | |||||
FCF Margin % | -784.43 | |||||
OCF Margin % | -759.29 | |||||
ROE % | -80.23 | |||||
ROA % | -65.02 | |||||
ROIC % | -65.4 | |||||
3-Year ROIIC % | 32.44 | |||||
ROC (Joel Greenblatt) % | -75.67 | |||||
ROCE % | -72.69 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.95 | |||||
PB Ratio | 0.31 | |||||
Price-to-Tangible-Book | 0.4 | |||||
EV-to-EBIT | -0.39 | |||||
EV-to-EBITDA | -0.95 | |||||
EV-to-Revenue | 8.32 | |||||
EV-to-FCF | -1.06 | |||||
Price-to-GF-Value | 0.8 | |||||
Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 0.8 | |||||
Earnings Yield (Greenblatt) % | -256.41 | |||||
FCF Yield % | -122.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cell Impact Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.533 | ||
| EPS (TTM) (€) | -0.047 | ||
| Beta | 4.5946 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 1.16 | ||
| Volatility % | 301.51 | ||
| 14-Day RSI | 46.58 | ||
| 14-Day ATR (€) | 0.008114 | ||
| 20-Day SMA (€) | 0.01292 | ||
| 12-1 Month Momentum % | 880.81 | ||
| 52-Week Range (€) | 0.0001 - 0.112676 | ||
| Shares Outstanding (Mil) | 487.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cell Impact Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cell Impact Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 125 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 48 days | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.02 (-28.83%) | ||
| General meeting for 2026 | 2026-04-23 14:00 | 0.01 (-45.00%) | ||
| Annual report for 2025 | 2026-03-20 | 0.01 (+5.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-04 | 0.03 (+117.39%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 0.02 (+0.00%) | ||
| 0.1:1 Stock Split | 2025-08-25 | 0.03 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.03 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-14 | 0.00 (-91.31%) |
Show
Entries
Cell Impact Frequently Asked Questions
What is Cell Impact(FRA:ICL)'s stock price today?
The current price of FRA:ICL is €0.01. The 52 week high of FRA:ICL is €0.11 and 52 week low is €0.00.
When is next earnings date of Cell Impact(FRA:ICL)?
The next earnings date of Cell Impact(FRA:ICL) is 2026-08-21.
Does Cell Impact(FRA:ICL) pay dividends? If so, how much?
Cell Impact(FRA:ICL) does not pay dividend.
Press Release
Articles on Cell Impact
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers